| Conformational targeting of intracellular Aβ oligomers demonstrates their pathological oligomerization inside the endoplasmic reticulum G Meli, A Lecci, A Manca, N Krako, V Albertini, L Benussi, R Ghidoni, ... Nature communications 5 (1), 3867, 2014 | 61 | 2014 |
| Characterization of mitochondrial dysfunction in the 7PA2 cell model of Alzheimer's disease N Krako, MC Magnifico, M Arese, G Meli, E Forte, A Lecci, A Manca, ... Journal of Alzheimer's Disease 37 (4), 747-758, 2013 | 38 | 2013 |
| Intrabodies for protein interference in Alzheimer’s disease G Meli, N Krako, A Manca, A Lecci, A Cattaneo J. Biol. Regul. Homeost. Agents 27, 89-105, 2013 | 4 | 2013 |
| O2‐04‐01: INTRACELLULAR ANTIBODIES FOR FUNCTIONAL INTERFERENCE WITH SUBCELLULAR AB OLIGOMERS G Meli, N Krako, A Manca, A Lecci, MC Magnifico, R Scardigli, P Sarti, ... Alzheimer's & Dementia 10, P170-P170, 2014 | | 2014 |
| Involvement of nitric oxide in bioenergetics: The Alzheimer's disease and the circadian rhythms M Arese, MC Magnifico, D Mastronicola, N Krako, E Forte, A Giuffré, ... BBA-Bioenergetics, e68-e69, 2014 | | 2014 |
| P2‐247: Conformational intrabodies targeting subcellular Aβ oligomers G Meli, A Lecci, N Krako, A Manca, V Albertini, R Ghidoni, A Cattaneo Alzheimer's & Dementia 7, S391-S391, 2011 | | 2011 |
| Interfering with the intracellular trafficking of Aß Oligomers with conformational intrabodies G Meli, A Lecci, N Krako, S Capsoni, A Cattaneo Society for Neuroscience 2010, abstract 48.19, 2010 | | 2010 |
| Generation and regulatory functions of the mitochondrial NAD pool M Aresea, MC Magnificob, D Mastronicolac, N Krakod, E Forteb, ... | | |
